No Significant Effect of the Individual Chronotype on the Result of Moderate Calorie Restriction for Obesity-A Pilot Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
15 Nov 2021
Historique:
received: 13 09 2021
revised: 04 11 2021
accepted: 09 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

Chronotype is the pattern of the circadian rhythm that allows an individual to optimize times of sleep and activity. It has been observed that chronotypes may associate with some conditions and diseases, including obesity. It is not known, however, whether chronotypes determine the effectiveness of weight loss regimens. Therefore, in the present study, we compared the outcomes of a 3-week moderate calorie restriction undertaken by individuals with obesity under the same controlled hospital conditions. A total of 131 participants with obesity (median BMI 40.0) were studied. The subjects underwent the same dietary intervention over 3 weeks, with a 30% reduction in daily caloric intake. The individual chronotypes were assessed by the morning and evening questionnaire (MEQ) according to Horne and Östberg. Anthropometric and biochemical parameters were assessed by routine methods. Of all patients examined, 75% had the morning (lark) chronotype and 25% had the evening (owl) chronotype. These patient sub-groups did not differ in terms of demographic, anthropometric and biochemical characteristics at baseline. After 3 weeks of calorie restriction, both groups experienced a similar loss of weight and BMI (Body Mass Index) (3.4 ± 0.38% for larks vs. 4.1 ± 0.47% for owls, The chronotype of individuals with obesity does not have a significant effect on the magnitude of the body weight loss, but there is a tendency observed towards the reduction in body fat content in owls through changing their meal and sleep timing to earlier hours, in response to moderate calorie restriction applied under the same controlled conditions.

Sections du résumé

BACKGROUND BACKGROUND
Chronotype is the pattern of the circadian rhythm that allows an individual to optimize times of sleep and activity. It has been observed that chronotypes may associate with some conditions and diseases, including obesity. It is not known, however, whether chronotypes determine the effectiveness of weight loss regimens. Therefore, in the present study, we compared the outcomes of a 3-week moderate calorie restriction undertaken by individuals with obesity under the same controlled hospital conditions.
METHODS METHODS
A total of 131 participants with obesity (median BMI 40.0) were studied. The subjects underwent the same dietary intervention over 3 weeks, with a 30% reduction in daily caloric intake. The individual chronotypes were assessed by the morning and evening questionnaire (MEQ) according to Horne and Östberg. Anthropometric and biochemical parameters were assessed by routine methods.
RESULTS RESULTS
Of all patients examined, 75% had the morning (lark) chronotype and 25% had the evening (owl) chronotype. These patient sub-groups did not differ in terms of demographic, anthropometric and biochemical characteristics at baseline. After 3 weeks of calorie restriction, both groups experienced a similar loss of weight and BMI (Body Mass Index) (3.4 ± 0.38% for larks vs. 4.1 ± 0.47% for owls,
CONCLUSIONS CONCLUSIONS
The chronotype of individuals with obesity does not have a significant effect on the magnitude of the body weight loss, but there is a tendency observed towards the reduction in body fat content in owls through changing their meal and sleep timing to earlier hours, in response to moderate calorie restriction applied under the same controlled conditions.

Identifiants

pubmed: 34836342
pii: nu13114089
doi: 10.3390/nu13114089
pmc: PMC8617879
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Chronobiol Int. 2017;34(3):393-402
pubmed: 28128995
Diabetes Care. 2013 Sep;36(9):2523-9
pubmed: 23637357
Diabetol Metab Syndr. 2020 Feb 10;12:13
pubmed: 32064002
Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1155-1165
pubmed: 30297199
Am J Clin Nutr. 2020 Nov 11;112(5):1348-1357
pubmed: 32860398
Eur J Public Health. 2019 Feb 1;29(1):128-134
pubmed: 29796606
Aging (Albany NY). 2016 Jul;8(7):1416-31
pubmed: 27410480
Obes Rev. 2020 Jun;21(6):e13000
pubmed: 31950676
Proc Natl Acad Sci U S A. 1918 Dec;4(12):370-3
pubmed: 16576330
Int J Obes (Lond). 2016 Oct;40(10):1550-1557
pubmed: 27339606
Int J Chronobiol. 1976;4(2):97-110
pubmed: 1027738
Chronobiol Int. 2020 May;37(5):673-685
pubmed: 32126839
J Clin Endocrinol Metab. 2003 Jun;88(6):2838-43
pubmed: 12788897
Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1199-208
pubmed: 24723555
Chronobiol Int. 2020 Jan;37(1):123-134
pubmed: 31747792
Front Physiol. 2019 Jun 25;10:787
pubmed: 31293451
J Biol Chem. 1992 Jul 25;267(21):14987-97
pubmed: 1321822
Sci Rep. 2018 Jan 17;8(1):945
pubmed: 29343740
J Behav Med. 2016 Jun;39(3):465-71
pubmed: 26660638
Occup Environ Med. 2014 Mar;71(3):195-200
pubmed: 24399070
Cytokine. 2015 Jun;73(2):265-9
pubmed: 25802195
Chronobiol Int. 2016;33(8):972-81
pubmed: 27246115
Int J Obes (Lond). 2015 Jan;39(1):39-44
pubmed: 25135376
PLoS One. 2013;8(3):e56519
pubmed: 23483886

Auteurs

Zofia Strojny (Z)

Department of Pathophysiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Rafał Rutkowski (R)

Department of Pathophysiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Alina Kanikowska (A)

Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Agnieszka Zawada (A)

Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Aldona Juchacz (A)

Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Marian Grzymisławski (M)

Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 60-355 Poznan, Poland.

Maki Sato (M)

Department of Physiology, Institutional Research, School of Medicine, Aichi Medical University, Aichi 480-1195, Japan.

Monika Litwinowicz (M)

Department of Pathophysiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Katarzyna Korybalska (K)

Department of Pathophysiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Andrzej Bręborowicz (A)

Department of Pathophysiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Janusz Witowski (J)

Department of Pathophysiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Dominika Kanikowska (D)

Department of Pathophysiology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH